Most Popular - Above The 200

Tempur Sealy’s Path to Dominance: Analyst’s Bullish Outlook Ahead of Mattress Firm Deal Tempur Sealy’s Path to Dominance: Analyst’s Bullish Outlook Ahead of Mattress Firm Deal

Tempur Sealy International Inc TPX is progressing to close the Mattress Firm acquisition this year. The Lexington, Kentucky-based company has emerged as a “dominant” player in the mattress industry and its multi-year growth outlook is “becoming highly attractive to long-term investors,” according to Piper Sandler. …

S&P 500 Surges; State Street Reports Strong Earnings – Anitra (AMEX:AZTR), C3is (NASDAQ:CISS) S&P 500 Surges; State Street Reports Strong Earnings – Anitra (AMEX:AZTR), C3is (NASDAQ:CISS)

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 0.95% to 37,824.10 while the NASDAQ rose 1.39% to 15,264.30. The S&P 500 also rose, gaining, 1.06% to 4,831.75. …

Is Microsoft Stock a Ticket to Retirement Riches?Is Microsoft Stock a Ticket to Retirement Riches?

Microsoft (NASDAQ: MSFT) stock has enamored numerous shareholders, transforming them into millionaires over the past several decades. The software behemoth’s climb toward a staggering $3 trillion of market capitalization has been nothing short of spectacular. Recently, it seized the throne from Apple as the world’s …

Earning Season: Top Picks for Investors Earning Season: Top Picks for Investors

Earnings season always offers a gripping peek behind the corporate curtain, a time when companies bare their financial souls to investors. The 2023 Q4 cycle looms large, a critical juncture where stakeholders eagerly seek insights into what lies ahead for 2024 and beyond. Chipotle Mexican …

What’s Behind the 12% Drop in Alibaba Stock in 2023 Analyzing the 12% Decline in Alibaba Stock Performance in 2023

Alibaba (NYSE: BABA), the Chinese e-commerce giant, encountered ongoing struggles in 2023, as the anticipated recovery in the Chinese economy failed to materialize. The company grappled with the continued loss of market share to PDD Holdings, and its plan to spin off non-core businesses was …

Analysis of Invesco RAFI Strategic US ETF and Its Market ActivityAssessment of Invesco RAFI Strategic US ETF and its Market Activity

Unusual Trading Volume Spotted In the world of exchange-traded funds (ETFs), the Invesco RAFI Strategic US ETF (IUS) turned heads on Friday with unprecedented trading volume. The ETF witnessed a surge as over 333,000 shares changed hands, significantly surpassing its three-month average volume of around …

Golden Cross Emerges For Morgan Stanley Stock On Q4 Earnings Beat Golden Cross Bodes Confidence for Morgan Stanley After Q4 Earnings

Milestone Achievement Morgan Stanley MS stock beat on EPS and revenue as it reported its fourth-quarter earnings on Jan. 16. Golden Cross and Bullish Sentiments Buoyed by positive sentiments around the company, the stock just made a Golden Cross on the technical price charts. On …

The Legal Battle between the SEC and Crypto Exchanges The Legal Battle between the SEC and Crypto Exchanges

Last summer, the U.S. Securities and Exchange Commission (SEC) filed lawsuits against prominent crypto exchanges Coinbase and Binance, alleging that they facilitated the trading of unregistered securities through various cryptocurrencies. This week, the courtroom hosted a tense face-off between the regulatory authority and the accused …

Copper Boosters Cheer As FCX Shines With Golden Cross Triumph – Freeport-McMoRan (NYSE:FCX) Copper Boosters Cheer As FCX Shines With Golden Cross Triumph – Freeport-McMoRan (NYSE:FCX)

Freeport-McMoRan Inc FCX stock just made a “golden cross,” one week ahead of reporting fourth-quarter (Q4) earnings. The 50-day SMA crossed over the 200-day SMA on Jan. 17, indicating a bullish trading sentiment over the stock. Also Read: Freeport-McMoRan Upgraded; Barrick Gold Downgraded; Commercial Metals …

TransCode Therapeutics Stock Plummets in Mid-Day Trading TransCode Therapeutics Stock Plummets in Mid-Day Trading

Shares of TransCode Therapeutics, Inc. RNAZ tumbled sharply during Friday’s session as the company priced a 5,942,623 share common stock offering at $1.22 per share, causing its shares to fall by 24.3% to $0.8248. Here are some other stocks moving in today’s mid-day session. Gainers …